Literature DB >> 21647121

When off label is off target.

.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21647121     DOI： 10.1038/nm0611-633

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Safety of recombinant activated factor VII in randomized clinical trials.

Authors:  Marcel Levi; Jerrold H Levy; Henning Friis Andersen; David Truloff
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

Review 2.  Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.

Authors:  Veronica Yank; C Vaughan Tuohy; Aaron C Logan; Dena M Bravata; Kristan Staudenmayer; Robin Eisenhut; Vandana Sundaram; Donal McMahon; Ingram Olkin; Kathryn M McDonald; Douglas K Owens; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

3.  Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records.

Authors:  Aaron C Logan; Veronica Yank; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391
  3 in total
  1 in total

1.  Off-label pharmacovigilance.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.